AbbVie to acquire Landos Biopharma to bolster autoimmune disease treatments

businessnewstoday- March 25, 2024 0

AbbVie Inc. (NYSE: ABBV) and Landos Biopharma, Inc. (NASDAQ: LABP) have announced a landmark agreement, marking a strategic move in the biopharmaceutical sector focused on ... Read More

EMA accepts MAA for Dong-A ST’s Stelara biosimilar, DMB-3115

businessnewstoday- July 17, 2023 0

Dong-A ST, the South Korean pharmaceutical company, has received confirmation from the European Medicine Agency (EMA) of the acceptance of their Marketing Authorization Application (MAA) ... Read More

Zydus Lifesciences gets FDA final approval for Balsalazide Disodium Capsules

businessnewstoday- June 10, 2023 0

Zydus Lifesciences, along with its subsidiaries and affiliates, has achieved a significant milestone with the final approval from the US Food and Drug Administration (FDA) ... Read More

Merck to acquire biotech company Prometheus Biosciences for $10.8bn

businessnewstoday- April 16, 2023 0

Merck has agreed to acquire Prometheus Biosciences, a Nasdaq-listed clinical-stage biotechnology company, in an all-cash deal worth around $10.8 billion, in a move to bolster ... Read More

Roivant Sciences, Pfizer create new business for inflammatory disease drug

Raghuram Kadari- December 3, 2022 0

Roivant Sciences, a US healthcare company, and Pfizer have established a new Vant to develop and commercialize PF-06480605 (now RVT-3101) for inflammatory and fibrotic bowel ... Read More

Alembic Pharmaceuticals gets FDA final approval for ulcerative colitis generic drug

businessnewstoday- November 2, 2022 0

Alembic Pharmaceuticals said that it has secured final approval for its abbreviated new drug application (ANDA) for Mesalamine Extended-Release Capsules USP, 0.375 g from the ... Read More

Biocon Biologics signs licensing deal for two biosimilars with Yoshindo

businessnewstoday- October 17, 2022 0

Biocon Ltd. said that its subsidiary Biocon Biologics has signed an out-licensing agreement with Japanese pharma company Yoshindo Inc. for commercializing a couple of its ... Read More

AzurRx BioPharma acquires US biotech company First Wave Bio for $229m

pallavi123- September 14, 2021 0

AzurRx BioPharma has signed a stock and cash deal worth $229 million to acquire Florida-based clinical-stage biotech company First Wave Bio. The consideration includes payments ... Read More

Zydus Cadila gets FDA approval for Mesalamine Extended-Release Capsules

pallavi123- August 16, 2021 0

Zydus Cadila said that it has secured final approval from the US Food and Drug Administration (FDA) to market Mesalamine Extended-Release Capsules in the strength ... Read More

Microbiome company Vedanta Biosciences raises $68m in Series D

pallavi123- July 21, 2021 0

Vedanta Biosciences, a clinical-stage microbiome company founded by PureTech Health, has raised $68 million in a Series D financing round led by affiliates of Magnetar ... Read More